Gu D - Search Results

1

Polymorphism rs2682818 in miR-618 is associated with colorectal cancer susceptibility in a Han Chinese population.

Chen Y, Du M, Chen W, Zhu L, Wu C, Zhang Z, Wang M, Chu H, Gu D, Chen J. Chen Y, et al. Among authors: gu d. Cancer Med. 2018 Apr;7(4):1194-1200. doi: 10.1002/cam4.1409. Epub 2018 Mar 13. Cancer Med. 2018. PMID: 29533012 Free PMC article.

2

XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.

Wang M, Gu D, Zhang Z, Zhou J, Zhang Z. Wang M, et al. Among authors: gu d. J Toxicol Environ Health A. 2009;72(11-12):698-705. doi: 10.1080/15287390902841029. J Toxicol Environ Health A. 2009. PMID: 19492231

3

The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.

Gu D, Wang M, Wang M, Zhang Z, Chen J. Gu D, et al. Mutagenesis. 2009 Nov;24(6):507-12. doi: 10.1093/mutage/gep036. Epub 2009 Sep 17. Mutagenesis. 2009. PMID: 19762350

4

Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.

Gu D, Wang M, Zhang Z, Chen J. Gu D, et al. Breast Cancer Res Treat. 2010 Jul;122(2):527-31. doi: 10.1007/s10549-009-0723-4. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054639 Review.

5

TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.

Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J. Gu D, et al. Breast Cancer Res Treat. 2010 Oct;123(3):857-61. doi: 10.1007/s10549-010-0766-6. Epub 2010 Feb 16. Breast Cancer Res Treat. 2010. PMID: 20157775

6

The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.

Chu H, Wang M, Wang M, Gu D, Wu D, Zhang Z, Tang J, Zhang Z. Chu H, et al. Among authors: gu d. Mutagenesis. 2010 Jul;25(4):389-95. doi: 10.1093/mutage/geq018. Epub 2010 Apr 23. Mutagenesis. 2010. PMID: 20418356

7

VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls.

Gu D, Wang M. Gu D, et al. Breast Cancer Res Treat. 2011 Jan;125(2):489-93. doi: 10.1007/s10549-010-0991-z. Epub 2010 Jun 19. Breast Cancer Res Treat. 2011. PMID: 20563637

8

Irinotecan-involved regimens for advanced gastric cancer: a pooled-analysis of clinical trials.

Wang DL, Gu DY, Huang HY, Xu Z, Chen JF. Wang DL, et al. World J Gastroenterol. 2010 Dec 14;16(46):5889-94. doi: 10.3748/wjg.v16.i46.5889. World J Gastroenterol. 2010. PMID: 21155012 Free PMC article.

9

The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.

Wang Q, Gu D, Wang M, Zhang Z, Tang J, Chen J. Wang Q, et al. Among authors: gu d. DNA Cell Biol. 2011 Jun;30(6):395-400. doi: 10.1089/dna.2010.1091. Epub 2011 Jan 8. DNA Cell Biol. 2011. PMID: 21214416

10

Clinical significance of expression of Hint1 and potential epigenetic mechanism in gastric cancer.

Huang H, Wei X, Su X, Qiao F, Xu Z, Gu D, Fan H, Chen J. Huang H, et al. Among authors: gu d. Int J Oncol. 2011 Jun;38(6):1557-64. doi: 10.3892/ijo.2011.994. Epub 2011 Apr 4. Int J Oncol. 2011. PMID: 21468541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,490 results

Search Page

Filters